Association Between Vitamin D Receptor Polymorphism and Familial Mediterranean Fever Disease in Turkish Children

S Kizildag1, F Dedemoglu2, A Anik3

  • 1Department of Medical Biology, Faculty of Medicine, Dokuz Eylül University, 35340, Balcova, Izmir, Turkey. sefa.kizildag@deu.edu.tr.

Biochemical Genetics
|January 9, 2016
PubMed

Insights

This study found no significant association between Vitamin D receptor (VDR) gene polymorphisms and Familial Mediterranean fever (FMF) risk in children. Further research in diverse populations is needed to explore VDR gene variations in FMF.

Area of Science:

  • Genetics
  • Immunology
  • Pediatrics

Background:

  • Familial Mediterranean fever (FMF) is an inherited autoinflammatory disorder causing recurrent fever and inflammation.
  • The role of genetic factors, including Vitamin D receptor (VDR) gene polymorphisms, in FMF susceptibility requires further investigation.

Purpose of the Study:

  • To investigate the potential association between specific VDR gene polymorphisms (FokI, TaqI, BsmI, ApaI) and the risk of FMF in pediatric patients.

Main Methods:

  • Polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) was used.
  • VDR gene polymorphisms (FokI, TaqI, BsmI, ApaI) were analyzed in 50 FMF patients and 150 healthy controls.

Main Results:

  • No statistically significant differences were observed in the genotype or allele frequencies of VDR FokI, TaqI, BsmI, and ApaI polymorphisms between FMF patients and the control group (p > 0.05).

Conclusions:

  • The studied VDR gene polymorphisms do not appear to be associated with FMF risk in this pediatric cohort.
  • Larger studies with diverse ethnic groups and haplotype analyses are recommended to fully elucidate the VDR gene's role in FMF pathogenesis.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.8K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.8K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.5K